These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19328444)

  • 41. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk.
    Barnes DE; Covinsky KE; Whitmer RA; Kuller LH; Lopez OL; Yaffe K
    Alzheimers Dement; 2010 Mar; 6(2):138-41. PubMed ID: 20298975
    [No Abstract]   [Full Text] [Related]  

  • 42. Recruitment and retention: challenges and opportunities for the NIA funded Alzheimer Disease Centers Program. Introduction.
    Austrom MG
    Alzheimer Dis Assoc Disord; 2010; 24 Suppl():S1. PubMed ID: 20802260
    [No Abstract]   [Full Text] [Related]  

  • 43. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Knopman DS; Haeberlein SB; Carrillo MC; Hendrix JA; Kerchner G; Margolin R; Maruff P; Miller DS; Tong G; Tome MB; Murray ME; Nelson PT; Sano M; Mattsson N; Sultzer DL; Montine TJ; Jack CR; Kolb H; Petersen RC; Vemuri P; Canniere MZ; Schneider JA; Resnick SM; Romano G; van Harten AC; Wolk DA; Bain LJ; Siemers E
    Alzheimers Dement; 2018 Apr; 14(4):563-575. PubMed ID: 29653607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Collaborating with industry--choices for the academic medical center.
    Moses H; Braunwald E; Martin JB; Thier SO
    N Engl J Med; 2002 Oct; 347(17):1371-5. PubMed ID: 12397200
    [No Abstract]   [Full Text] [Related]  

  • 45. National Institute of Neurological and Communicative Disorders and Stroke. The dementias: hope through research.
    J Am Health Care Assoc; 1982 May; 8(3):35-44. PubMed ID: 10317201
    [No Abstract]   [Full Text] [Related]  

  • 46. The growth and impact of Alzheimer disease centers as measured by social network analysis.
    Hughes ME; Peeler J; Hogenesch JB; Trojanowski JQ
    JAMA Neurol; 2014 Apr; 71(4):412-20. PubMed ID: 24514750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Largest ever funding for multiple sclerosis research projects.
    Hayward P
    Lancet Neurol; 2005 Oct; 4(10):598. PubMed ID: 16208855
    [No Abstract]   [Full Text] [Related]  

  • 48. Publishing affects funding in neurology.
    Gilhus NE; Sivertsen G
    Eur J Neurol; 2010 Jan; 17(1):147-51. PubMed ID: 19765056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The crisis in scholarly publishing: open access to the rescue?
    Oren GA
    J Neuroophthalmol; 2008 Mar; 28(1):1-4. PubMed ID: 18347450
    [No Abstract]   [Full Text] [Related]  

  • 50. Is medical research doomed?
    Hudson T
    Hosp Health Netw; 1997 Oct; 71(20):40-4. PubMed ID: 9401471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An AUPN/ANA survey of department leader opinions on the health of US academic neurology.
    Greenberg JO
    Neurology; 2005 May; 64(9):1664; author reply 1664. PubMed ID: 15883349
    [No Abstract]   [Full Text] [Related]  

  • 52. The NIH Roadmap. strategies to accelerate medical research progress.
    Funct Neurol; 2004; 19(3):165-6. PubMed ID: 15595710
    [No Abstract]   [Full Text] [Related]  

  • 53. Financial conflict of interest: an unresolved ethical frontier.
    Kassirer JP
    Am J Law Med; 2001; 27(2-3):149-62. PubMed ID: 11467107
    [No Abstract]   [Full Text] [Related]  

  • 54. Academic Medical Centers: Too Large for Their Own Health?
    Johnston SC
    JAMA; 2019 Jul; 322(3):203-204. PubMed ID: 31206135
    [No Abstract]   [Full Text] [Related]  

  • 55. Academic medical centers and medical research: the challenges ahead.
    Cohen JJ; Siegel EK
    JAMA; 2005 Sep; 294(11):1367-72. PubMed ID: 16174695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors.
    Snyder PJ; Papp KV; Bartkowiak J; Jackson CE; Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):122-4. PubMed ID: 19328439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Data sharing: making headway in a competitive research milieu.
    Samson K
    Ann Neurol; 2008 Jul; 64(1):A13-6. PubMed ID: 18668610
    [No Abstract]   [Full Text] [Related]  

  • 58. Academic medical centers' standards for clinical-trial agreements with industry.
    Mello MM; Clarridge BR; Studdert DM
    N Engl J Med; 2005 May; 352(21):2202-10. PubMed ID: 15917385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advancing the framework: use of health data--a report of a working conference of the American Medical Informatics Association.
    Bloomrosen M; Detmer D
    J Am Med Inform Assoc; 2008; 15(6):715-22. PubMed ID: 18755988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. National Institutes of Health eliminates funding for national architecture linking primary care research.
    Peterson KA
    J Am Board Fam Med; 2007; 20(2):229-31. PubMed ID: 17341760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.